@article{JTD534,
author = {Paul Zarogoulidis and Theodora Kerenidi and Haidong Huang and Theodoros Kontakiotis and Ourania Tremma and Konstantinos Porpodis and Anastasios Kalianos and Ageliki Rapti and Christoforos Foroulis and Athanasios Zissimopoulos and Nikolaos Courcoutsakis and Konstantinos Zarogoulidis},
title = {Six minute walking test and carbon monoxide diffusing capacity for non-small cell lung cancer. Easy performed tests in every day practice},
journal = {Journal of Thoracic Disease},
volume = {4},
number = {6},
year = {2012},
keywords = {},
abstract = {Background: Several studies have demonstrated that reduced lung function is a significant risk factor for lung cancer and increased surgical risk in patients with operable stages of lung cancer. The aim of the study was to perform pulmonary function tests and investigate which is a favorable respiratory function test for overall survival between lung cancer stages. Methods: Lung function tests were performed to lung cancer patients with non-small cell lung cancer of stage I, II, III and IV (241 patients in total). They had the last follow-up consecutively between December 2006 and July 2008. The staging was decided according to the sixth edition of TNM classification of NSCLC. The Forced Expiratory Volume in 1sec (FEV1), Forced Vital Capacity (FVC) and Carbon Monoxide Diffusing Capacity (DLCO) were measured according to American Thoracic Society/European Respiratory Society guidelines. The 6 Minute Walking Test (6MWT) was measured according to the American Thoracic Society. Results: There was a significant association of the DLCO upon diagnosis and overall survival for stage II (P},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/534}
}